Patent ID: 9285378
Filing Date: 2016-03-15
CPC Classification: A61B,G01N

Claim Text:
1. A method for diagnosing heart failure in a subject comprising: a) detecting in a sample of a subject suspected to suffer from heart failure, but not exhibiting heart failure symptoms as described according to New York Heart Association class IV, the amount of at least one biomarker selected from the group consisting of cholesterylester C18:1 and cholesterylester C18:2, wherein the sample is a plasma or serum sample; b) pre-treating the sample using an extraction step prior to detecting the amount of the at least one biomarker c) comparing the amount of said at least one biomarker to a reference, whereby heart failure is to be diagnosed i) if the amount of said at least one biomarker is significantly decreased as compared to the reference when the reference is derived from a subject or group of subjects known not to suffer from heart failure or is a calculated reference; or ii) if the amount of said at least one biomarker is essentially identical to the reference when the reference is derived from a subject or group of subjects known to suffer from heart failure.